健康志愿者静息状态下18F-Flurpiridaz全身动力学首次研究及简化定量策略可行性
60分钟时2T4K模型在18个靶区中的15个AIC更低;30分钟和60分钟Logan VT与参考VT强相关,注射后约10分钟SUVmean也强相关,支持超短成像策略。
要点
- 2T4K模型在60分钟时对多数器官拟合更优,支持多器官定量。
- 30分钟和60分钟Logan VT与参考VT强相关,可简化采集。
- 注射后约10分钟SUVmean与参考VT强相关,提示超短成像可行。
核心结论
- 18F-flurpiridaz全身动力学图谱支持2T4K模型用于多器官定量,并提示超短成像策略可行。
研究设计与样本
- 采用自动CT分割法生成感兴趣体积并提取时间-放射性曲线,降主动脉作为多数器官输入函数,肺动脉用于肺。
- 比较含血容量和时间延迟校正的2T3K与2T4K房室模型,用AIC评价拟合优度。
主要发现
- 不同器官呈现四种 distinct 动力学模式。
- 60分钟时2T4K模型在18个靶区中的15个AIC更低。
- 心脏、脑和肾脏在10分钟时2T3K模型AIC更低。
- 甲状腺和脊髓的最优模型从60分钟的2T3K转变为10分钟的2T4K。
- 30分钟Logan VT(r=0.974)和60分钟Logan VT(r=0.979)与参考VT强相关。
关键数值与推荐
- 注射后约10分钟SUVmean与参考VT强相关(r=0.834-0.909),略低于最佳25-30分钟窗口(r=0.922;所有P<0.0001)。
临床怎么用
- 可利用2T4K模型进行多器官定量,并根据时间依赖的模型偏好选择拟合模型。
- 30分钟或更短扫描的简化定量指标与60分钟参考VT强相关,支持临床转化中的超短成像策略。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The multiorgan kinetic profile of 18F-flurpiridaz targeting mitochondrial complex I remains inadequately characterized. We aim to characterize preliminary total-body pharmacokinetics of 18F-flurpiridaz in healthy volunteers and evaluate shortened acquisition protocols for clinical translation. Methods: Twelve healthy volunteers were imaged with 18F-flurpiridaz during a 60-min dynamic total-body PET/CT scan on the uEXPLORER scanner at rest. Time-activity curves were derived from volumes of interest generated by an automated CT-based segmentation method applied to motion-corrected dynamic PET images, with manual delineation of the descending aorta, kidney, and breasts. The descending aorta served as the input function for most organs, whereas the pulmonary artery was used for the lungs. The 2-tissue irreversible (2T3K) and 2-tissue reversible (2T4K) compartment models incorporating blood volume and time-delay correction were compared using the Akaike information criterion (AIC). Simplified metrics of distribution volume (V T) from a Logan plot and SUVmean from truncated scans (10, 30, and 60 min) were correlated with the reference 60-min 2T4K V T Results: Four distinct kinetic patterns were observed across different organs. At 60 min, the 2T4K model demonstrated superior fitting performance (lower AIC) in 15 of 18 targeted regions. The 2T3K model exhibited lower AIC in the heart, brain, and kidneys at 10 min. In the thyroid and spinal cord, the optimal model shifted from the 2T3K model at 60 min to the 2T4K model at 10 min. Logan V T from 30-min (r = 0.974) and 60-min (r = 0.979) scans strongly correlated with reference V T Notably, SUVmean around 10-min postinjection also showed strong correlation with reference V T (r = 0.834-0.909), only slightly lower than that observed in the optimal 25-30-min window (r = 0.922; all P < 0.0001). Conclusion: This total-body kinetic atlas of 18F-flurpiridaz supports the use of the 2T4K model for multiorgan quantification, time-dependent model preference, and the feasibility of ultrashort imaging strategies for clinical mitochondrial complex I assessment, establishing a foundation for future applications in oncology (e.g., metabolism evaluation), neurology (e.g., mitochondrial mapping), and integrated cardio-oncology diagnostics.
引用
- Song H, Xiang Z, Wang Y, et al. First Total-Body Kinetics Study of 18F-Flurpiridaz in Healthy Volunteers at Rest and Feasibility of Simplified Quantitative Strategies. J Nucl Med. 2026. PMID: 41927281. doi:10.2967/jnumed.125.270997
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。